Baxter International Inc vs 3M Company — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.26B), while 3M Company trades at $156.2 (market cap $81.67B). The key difference: 3M Company is far larger — about 7.3× Baxter International Inc's market cap, and 3M Company pays the higher dividend (1.99%). Which is the better fit depends on your goals.
| BAX | MMM | |
|---|---|---|
Market Cap | $11.26B | $81.67B |
Sector | Health | Industrials |
52-Week High | $29.22 | $174.61 |
52-Week Low | $15.80 | $141.10 |
Enterprise Value | $18.93B | $90.07B |
Dividend Yield | 0.92% | 1.99% |
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
3M (MMM) trades at $157.70, showing minimal daily movement with a 0.11% gain. The stock faces technical headwinds with bearish moving averages but maintains strong profitability metrics including a 72.14% ROE and consistent earnings beats. Recent developments include new product launches and strategic partnerships, though the company navigates consumer segment weakness and mixed analyst sentiment.
The outlook remains balanced with solid fundamentals supporting long-term value, but near-term risks include competitive pressures and macroeconomic sensitivity. Analyst consensus suggests cautious optimism with a $143 price target, while technical indicators signal potential consolidation around current levels.
Trailing returns across standard periods
Latest headlines on both assets
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →